Butts C, Socinski MA, Mitchell PL, et al. Tecemotide (L -BLP25) versus pl acebo after chemoradiotherapy for stage III non -small -cell lung cancer (START): a randomised, double - blind, phase 3 trial. The Lancet Oncology 2014;15:59 -68. 11. Nemunaitis J, Nemunaitis M, Senzer N, et al. Phase II trial of Belagenpumatucel -L, a TGF - beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. Cancer gene therapy 2009;16:620 -4. 12. Giaccone G, Bazhenova LA, Nemunaitis J, et al. A phase III study of belagenpumatucel -L, an allogeneic tumour c ell vaccine, as maintenance therapy for non -small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2015;51:2321 -9.